The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index; none of the 61 sources its claims cite is checked for support yet.
TMEM119+ microglia MHC class I restricted antigen presentation impacts CD8 T cell memory, effector status, and blood-brain barrier disruption during neurotropic virus infection
Open accessAbstract
The impact of microglia antigen presentation on CNS infiltrating CD8 T cells responses during neurotropic virus infection remains undefined. Using Theiler’s murine encephalomyelitis virus (TMEV) infection of neurons as a model system, we generated H-2K b and H-2D b Tmem119 conditional knockout mice. During TMEV infection, we determined using Tmem119 K b cKO mice that microglia H-2K b contributes to antiviral CD8 T cell proliferation in the brain. Meanwhile, using Tmem119 D b cKO mice we determined that microglia H-2D b increased antiviral CD8 T cell perforin levels and the capacity to induce blood-brain barrier (BBB) disruption. Furthermore, microglial H-2D b was essential for antigen-specific reactivation of CD8 tissue resident memory (TRM) cell recall responses and BBB disruption long after virus had been cleared. These findings demonstrate discrete roles of individual MHC class I genes on microglia in CD8 T cell proliferation, effector functions, memory recall and neuropathology.
Overview
CoChat Summary
TL;DR
Using Tmem119-CreERT2 conditional knockout mice for H-2Kb or H-2Db, this study shows that microglial MHC class I molecules have discrete roles during TMEV infection: microglial H-2Kb supports CD8 T cell proliferation in the brain, while microglial H-2Db promotes perforin expression, blood-brain barrier disruption, and CD8 tissue-resident memory recall. The effects are CNS-localized and, for memory recall, occur long after virus clearance.
Key findings
- In TMEV-OVA infection, Tmem119 Kb cKO mice had a marked reduction in Kb:OVA epitope-specific CD8 T cells in the brain at 7 days post-infection; BrdU/FTY720 experiments showed decreased BrdU+ and antiviral Kb:OVA CD8 T cells, indicating microglial H-2Kb is required for optimal CD8 T cell proliferation in the brain. Parabiosis with a Cre− littermate did not restore these reductions, indicating the stimulation occurs within the brain.
- In TMEV infection, Tmem119 Db cKO mice at 7 days post-infection showed no change in Db:VP2121–130 tetramer+ CD8 T cell frequencies, but had reduced perforin protein levels and reduced percentages of perforin+ CD8 T cells and Db:VP2121–130 tetramer+ CD8 T cells. In the peptide-induced fatal syndrome model, Tmem119 Db cKO mice had reduced infiltrating CD45hi cells, total T cells, CD8 T cells, and Db:VP2121–130 tetramer+ CD8 T cells, plus reduced FITC-albumin leakage; parabiosis did not restore BBB disruption.
- At 30 days post-infection, Tmem119 Db cKO and Cre− controls had similar numbers of Db:VP2121–130 tetramer+ CD8 T cells and CD69+CD103+ cells. After peptide reactivation, however, Tmem119 Db cKO mice showed decreased Db:VP2121–130 tetramer+ CD8 T cell expansion, reduced total infiltrating CD45hi cells and CD11b+MHC II+ myeloid cells, and reduced gadolinium leakage by MRI when the CD8 TRM response was isolated with FTY720.
Methods
- Generated tamoxifen-inducible Tmem119-CreERT2 × H-2Kb fl/fl or H-2Db fl/fl conditional knockout mice; used 10–15-week-old male and female mice with age- and sex-matched controls. Tamoxifen was given at 75 mg/kg i.p. at 8 weeks for 5 consecutive days for Kb cKO mice, or 5 days followed by 1 week recovery and 5 additional days for Db cKO mice.
- Infected mice intracranially with TMEV Daniel’s strain (2 × 10^6 PFU) or TMEV-OVA (2 × 10^5 PFU). Analyzed brain-infiltrating leukocytes by spectral flow cytometry at 7 days post-infection or later, using FTY720, BrdU, intravascular CD45 labeling, FITC-albumin leakage, MRI, parabiosis, and peptide reactivation with VP2121–130 or control E7 peptide.
- Statistics used unpaired or paired Student’s t-tests, one-way ANOVA with Tukey’s post hoc test, or two-way ANOVA with Šidák’s test; analyses performed in Prism 10.0, Excel, or R; data presented as mean ± SD.
Limitations
- Stated in the paper: the mechanisms underlying microglial antigen presentation are still unknown; it is unclear whether modulation of perforin and BBB damage would be beneficial in different disease models; future studies are needed to investigate this form of regulation; and more studies are needed to confirm the dynamics in other disease models.
- Evident from the text: many results are described qualitatively in the prose (e.g., “marked reduction,” “no differences”) without numeric effect sizes or confidence intervals, though figures contain quantification not available in the provided text.
- Evident from the text: although male and female mice were used, no sex-specific analyses or differences are reported; the text also identifies itself as a preprint with supplementary files.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
0 Valid · 0 Not valid · 35 Not checked · 85 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Microglial MHC class I contributes to the expansion of CD8 TRM cell populations in the brain during antigen recall response”
§ TMEM119+ microglia MHC class I restricted antigen presentation impacts CD8 T cell memory, effector status, and blood-brain barrier disruption during neurotropic virus infection > Results > Microglial MHC class I contributes to the expansion of CD8 TRM cell populations in the brain during antigen recall response
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, Tmem119 Db cKO mice that received VP2121–130 injection exhibited a decrease in the immune cell infiltration in comparison to Cre-littermates that also received VP2121–130 (Figure 7D).”
§ TMEM119+ microglia MHC class I restricted antigen presentation impacts CD8 T cell memory, effector status, and blood-brain barrier disruption during neurotropic virus infection > Results > Microglia MHC class I antigen presentation does not affect the generation of memory CD8 T cells
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“48 hours after VP2121–130 or control E7 peptide, we observed an increase in the numbers of infiltrating cells in both Tmem119 Db cKO mice and Cre-littermate controls (Figure 7D).”
§ TMEM119+ microglia MHC class I restricted antigen presentation impacts CD8 T cell memory, effector status, and blood-brain barrier disruption during neurotropic virus infection > Results > Microglia MHC class I antigen presentation does not affect the generation of memory CD8 T cells
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“CD8 T cell proliferation is attenuated when Kb is conditionally ablated in microglia during acute infection”
§ TMEM119+ microglia MHC class I restricted antigen presentation impacts CD8 T cell memory, effector status, and blood-brain barrier disruption during neurotropic virus infection > Results > CD8 T cell proliferation is attenuated when Kb is conditionally ablated in microglia during acute infection
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This population was attenuated in the Tmem119 Db cKO mice”
§ TMEM119+ microglia MHC class I restricted antigen presentation impacts CD8 T cell memory, effector status, and blood-brain barrier disruption during neurotropic virus infection > Results > Microglia MHC class I antigen presentation does not affect the generation of memory CD8 T cells
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
68 more claims
Create a free account to see all 120 claims and to verify the 58 references still open.
- It may state two separate claims as one. 33
- Probably not a substantial claim. 16
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ TMEM119+ microglia MHC class I restricted antigen presentation impacts CD8 T cell memory, effector status, and blood-brain barrier disruption during neurotropic virus infection > Results > Microglial MHC class I contributes to the expansion of CD8 TRM cell populations in the brain during antigen recall response
“FTY720 was administered 3 days prior VP2121–120 i.v injection and 2 days after to restimulate memory Db:VP2121–130 epitope specific CD8 TRM cells”
§ TMEM119+ microglia MHC class I restricted antigen presentation impacts CD8 T cell memory, effector status, and blood-brain barrier disruption during neurotropic virus infection > Methods > Reactivation of virus antigen-specific CD8 T cells through peptide injection
“Between 55–65 days post-TMEV infection, mice were intravenously injected with 0.1 mg (from a solution of 1mg/ml in PBS) of VP2121–130 (FHAGSLLVFM) or control E7 (RAHYNIVTF) peptide”
Citations
Cites
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,552
Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial γδ T Cells
Groh, V., Steinle, A., Bauer, S., & Spies, T. (1998) · Science · doi:10.1126/science.279.5357.1737 · Cited by 1,142
Dual microglia effects on blood brain barrier permeability induced by systemic inflammation
Haruwaka, K., Ikegami, A., Tachibana, Y., Ohno, N., Konishi, H., Hashimoto, A., Matsumoto, M., Kato, D., Ono, R., Kiyama, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13812-z · Cited by 923
Cross-priming in health and disease
Kurts, C., Robinson, B. W. S., & Knolle, P. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2780 · Cited by 429
Tissue-resident memory T cells populate the human brain
Smolders, J., Heutinck, K. M., Fransen, N. L., Remmerswaal, E. B. M., Hombrink, P., ten Berge, I. J. M., van Lier, R. A. W., Huitinga, I., & Hamann, J. (2018) · Nature Communications · doi:10.1038/s41467-018-07053-9 · Cited by 406
Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5610-12.2013 · Cited by 406
Ronaldson, P. T., & Davis, T. P. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20951995 · Cited by 392
Neuroinflammation: Microglia and T Cells Get Ready to Tango
Schetters, S. T. T., Gomez-Nicola, D., Garcia-Vallejo, J. J., & Van Kooyk, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01905 · Cited by 382
Cited by
Still being checked.
Metadata
- Authors
- Johnson, A., Seady, M., Maynes, M., Thelwell, J., Jin, F., Hansen, M., Jensen, H., Witter, R., Owens, C., Hassani, A., Lewis, C., & Forston, M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Johnson, Aaron
- Venue
- Research Square
- Published
- 2026-06-24
- PMC
- PMC13321286
- OpenAlex
- W7160888065
- Cited by
- 0
- References
- 59
- Type
- posted content
- Language
- en
- Open access
- green
- doi.org
- Locations
- Research Square (submittedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (submittedVersion)
- PubMed Central (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (T32AI170478)
- National Institute of Neurological Disorders and Stroke (R01NS122174, R01NS103212)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- TMEM119, microglia, MHC class I antigen presentation, H-2Kb, H-2Db, CD8+ T cells, tissue-resident memory T cells, Theiler's murine encephalomyelitis virus, blood-brain barrier disruption, perforin, conditional knockout mice, CNS immune response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TMEM119+ microglia MHC class I restricted antigen presentation impacts CD8 T cell memory, effector status, and blood-brain barrier disruption during neurotropic virus infection. https://app.cochat.ai/papers/10.21203/rs.3.rs-10061124/v1
- The paper
- Johnson, A., Seady, M., Maynes, M., Thelwell, J., Jin, F., Hansen, M., Jensen, H., Witter, R., Owens, C., Hassani, A., Lewis, C., & Forston, M. (2026). TMEM119+ microglia MHC class I restricted antigen presentation impacts CD8 T cell memory, effector status, and blood-brain barrier disruption during neurotropic virus infection. Research Square. https://doi.org/10.21203/rs.3.rs-10061124/v1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.